RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
RICOVR Healthcare has raised $550K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2026.
RICOVR Healthcare's investors include HALLEY Venture Partners, Commission on Science, Innovation and Technology, National Heart, Lung and Blood Institute, National Institute on Drug Abuse (NIDA).
RICOVR Healthcare is headquartered in Princeton, United States.
RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
RICOVR Healthcare is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RICOVR Healthcare — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/ricovr-healthcare. Accessed November 14, 2026.
VCBacked. (2026). RICOVR Healthcare — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/ricovr-healthcare
{{cite web |title=RICOVR Healthcare — Funding & Investors |url=https://www.vcbacked.co/company/ricovr-healthcare |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at RICOVR Healthcare? Request a listing update